---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-019839"
form_type: "8-K"
ticker: "CELU"
cik: "0001752828"
company_name: "Celularity Inc"
filed_at: "2025-10-28T23:59:59+00:00"
generated_at: "2026-05-17T01:57:54.798996+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Celularity raises $2M initial tranche in $6.67M private placement of Series A Preferred and warrants

## Summary
- Series A Preferred shares sold at 90% of stated value; $2M initial tranche closed Oct 24, 2025.
- Up to three tranches totaling $6.67M stated value; warrants exercisable at $3.00/share for 25% of purchase price.
- Conversion price lower of 110% of prior close or 95% of 7-day VWAP, floor $1.60; 5% dividend (18% on trigger event).
- Proceeds used for working capital; investor capped at 4.99% beneficial ownership unless waived.
- Shares issued exempt under Section 4(a)(2) and Regulation D; resale registration required within 30 days.

## SEC filing metadata
- accession: 0001493152-25-019839
- form_type: 8-K
- ticker: CELU
- cik: 0001752828
- company_name: Celularity Inc
- filed_at: 2025-10-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1752828/000149315225019839/0001493152-25-019839-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1752828/000149315225019839/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-019839
- JSON: https://secwatch.observer/filing/0001493152-25-019839.json
- Plain text: https://secwatch.observer/filing/0001493152-25-019839.txt

## Key facts
- Equity Issuances
  Celularity Inc issued preferred stock to an institutional investor for 90% of the stated value.
  - Security: preferred stock
  - Purchaser: an institutional investor
  - Consideration: 90% of the stated value
  source text: with the Series A Preferred Stock, the “Securities”). Under the Purchase Agreement, the Series A Preferred Stock will be issued and sold at a purchase price equal to 90% of the stated value, with each Preferred Share having a stated value of $1.111111 per share, and the Warrants will be issued for no additional consideration. Each Warrant will
  evidence_url: https://www.sec.gov/Archives/edgar/data/1752828/000149315225019839/0001493152-25-019839-index.htm
- Governance Changes
  Celularity Inc: Filed Certificate of Designation for Series A Convertible Preferred Stock, establishing rights and preferences for 6,000,000 shares of Series A Preferred Stock (effective 2025-10-24).
  - Change: charter amendment
  - Effective: 2025-10-24
  source text: On October 24, 2025, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, designating 6,000,000 shares of Series A Preferred Stock, out of the Company’s authorized preferred stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1752828/000149315225019839/0001493152-25-019839-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.